Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
Laetril, also known as B-17, is a chemical compound related to amygdalin, a natural substance found in the seeds or pits of fruits like apricots, bitter almonds, peaches, and cherries. It has been promoted as an alternative cancer treatment, often under the name vitamin B17, though it is not a vitamin. Laetril is not part of standard cancer care and is not approved by medical authorities such as the U.S. Food and Drug Administration (FDA).
Some patients explore alternative or complementary therapies during cancer treatment, and Laetril is one of the substances they may encounter. It has been promoted by certain clinics and communities as a way to fight cancer, boost the immune system, or detoxify the body. However, scientific studies have not shown Laetril to be effective in treating cancer. Moreover, Laetril can break down in the body to release cyanide, a toxic substance that can cause serious harm or even death. Using Laetril instead of proven treatments may delay effective care and increase health risks.
Patients may come across Laetril under different names, including B-17 or vitamin B17. It might appear in alternative health discussions, patient forums, or in some clinics offering nonstandard therapies. Sometimes it is mentioned in treatment plans or clinical trial listings focused on alternative medicine. Hearing about Laetril does not mean it is recommended or safe. It is important to understand that Laetril is not supported by reliable scientific evidence and is not included in cancer treatment guidelines.
Because Laetril is sometimes called vitamin B17, people may mistakenly believe it is an essential nutrient or a proven cancer treatment. This is not true. It is not recognized as a vitamin by nutrition experts. Laetril is chemically related to amygdalin, which also carries risks of cyanide poisoning. Patients often ask their doctors about the safety and effectiveness of Laetril, and it is important to have open conversations to understand the potential harms and lack of proven benefits.
Laetril can release cyanide in the body, which is poisonous and can be life-threatening. Because of this risk and the lack of evidence supporting its use, Laetril is not approved for cancer treatment in the United States or most other countries. This information is meant to educate and should not replace medical advice. If you are curious or concerned about Laetril, the best step is to discuss it openly with your healthcare team. They can provide reliable information, explain current research, and help guide you toward safe and effective treatment options that fit your diagnosis and goals.
Public source information used for this glossary entry includes: